_tackling-nitrosamine-impurities-in-medicines-preview-1.jpg "Tackling nitrosamine impurities in medicines from usp 1469 nitrosamine impurities Video Screenshot Preview 1")
Gallery_tackling-nitrosamine-impurities-in-medicines-preview-3.jpg "Tackling nitrosamine impurities in medicines from usp 1469 nitrosamine impurities Video Screenshot Preview 3")
Gallery_tackling-nitrosamine-impurities-in-medicines-preview-hqdefault.jpg "Tackling nitrosamine impurities in medicines from usp 1469 nitrosamine impurities Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 23 seconds
👁 View: 7.3K times
Play Audio:👁 View: 7.3K times
Description:
US Pharmacopeia
US Pharmacopeia
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_testing-methods-for-nitrosamines-monitoring-in-pharmaceuticals-gc-1469.webp "US Pharmacopeia")
⏲ 1 hour 12 minutes 20 seconds 👁 1.4K
_nitrosamine-impurities-124-usp.webp "US Pharmacopeia")
_analytical-solutions-for-nitrosamines-in-response-to-usp.webp "Shimadzu Scientific Instruments")
_nitrosamine-impurities-aug-2023-ndsris-limit-usfda-guidance-124-control-of-nitrosamine-guidance-feb-21.webp "ProfTalks")
Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
⏲ 44 minutes 52 seconds 👁 5.4K
_overview-of-the-guidance-for-industry-control-of-nitrosamine-impurities-in-human-drugs.webp "U.S. Food and Drug Administration")
⏲ 1 hour 22 minutes 14 seconds 👁 7.5K
_impurities-in-drug-substances-products-global-guidances-amp-usp-perspective.webp "US Pharmacopeia")
⏲ 39 minutes 13 seconds 👁 3K
_validation-verification-amp-transfer-of-analytical-methods-usp-general-chapters-1224-1225-amp-1226.webp "US Pharmacopeia")
⏲ 58 minutes 50 seconds 👁 14.3K
_introduction-to-analytical-quality-by-design-aqbd-principles.webp "US Pharmacopeia")
_testing-methods-for-nitrosamines-monitoring-in-pharmaceuticals-gc-1469.jpg)
_nitrosamine-impurities-124-usp.jpg)
_analytical-solutions-for-nitrosamines-in-response-to-usp.jpg)
_nitrosamine-impurities-aug-2023-ndsris-limit-usfda-guidance-124-control-of-nitrosamine-guidance-feb-21.jpg)
_overview-of-the-guidance-for-industry-control-of-nitrosamine-impurities-in-human-drugs.jpg)
_impurities-in-drug-substances-products-global-guidances-amp-usp-perspective.jpg)
_validation-verification-amp-transfer-of-analytical-methods-usp-general-chapters-1224-1225-amp-1226.jpg)
_introduction-to-analytical-quality-by-design-aqbd-principles.jpg)
![[+]](/images/menu.gif){kind=small}